Your browser doesn't support javascript.
loading
First-In-Human Study of Cemiplimab Alone or In Combination with Radiotherapy and/or Low-dose Cyclophosphamide in Patients with Advanced Malignancies.
Papadopoulos, Kyriakos P; Johnson, Melissa L; Lockhart, Albert C; Moore, Kathleen; Falchook, Gerald S; Formenti, Silvia C; Naing, Aung; Carvajal, Richard D; Rosen, Lee S; Weiss, Glen J; Leidner, Rom S; Li, Jingjin; Paccaly, Anne; Feng, Minjie; Stankevich, Elizabeth; Lowy, Israel; Fury, Matthew G; Crittenden, Marka R.
Afiliação
  • Papadopoulos KP; START, San Antonio, Texas. Kyri.Papadopoulos@startsa.com.
  • Johnson ML; Sarah Cannon Research Institute, Nashville, Tennessee.
  • Lockhart AC; Department of Medicine, Washington University in St. Louis, St. Louis, Missouri.
  • Moore K; Stephenson Cancer Center at the University of Oklahoma Health Sciences Center/Sarah Cannon Research Institute, Oklahoma City, Oklahoma.
  • Falchook GS; Sarah Cannon Research Institute at HealthONE, Denver, Colorado.
  • Formenti SC; Department of Radiation Oncology, Weill Cornell Medicine, New York, New York.
  • Naing A; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Carvajal RD; Division of Hematology/Oncology, Columbia University Medical Center, New York, New York.
  • Rosen LS; UCLA Division of Hematology-Oncology, Santa Monica, California.
  • Weiss GJ; Western Regional Medical Center, Goodyear, Arizona.
  • Leidner RS; Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, Oregon.
  • Li J; Regeneron Pharmaceuticals, Inc., Basking Ridge, New Jersey.
  • Paccaly A; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.
  • Feng M; Regeneron Pharmaceuticals, Inc., Basking Ridge, New Jersey.
  • Stankevich E; Regeneron Pharmaceuticals, Inc., Basking Ridge, New Jersey.
  • Lowy I; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.
  • Fury MG; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.
  • Crittenden MR; Earle A. Chiles Research Institute and The Oregon Clinic, Portland, Oregon.
Clin Cancer Res ; 26(5): 1025-1033, 2020 03 01.
Article em En | MEDLINE | ID: mdl-31796520
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Quimiorradioterapia / Critérios de Avaliação de Resposta em Tumores Sólidos / Neoplasias Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Quimiorradioterapia / Critérios de Avaliação de Resposta em Tumores Sólidos / Neoplasias Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos